145 related articles for article (PubMed ID: 10874299)
1. Private beta- and gamma-sarcoglycan gene mutations: evidence of a founder effect in Northern Italy.
Fanin M; Hoffman EP; Angelini C; Pegoraro E
Hum Mutat; 2000; 16(1):13-7. PubMed ID: 10874299
[TBL] [Abstract][Full Text] [Related]
2. Genetic epidemiology of muscular dystrophies resulting from sarcoglycan gene mutations.
Fanin M; Duggan DJ; Mostacciuolo ML; Martinello F; Freda MP; Sorarù G; Trevisan CP; Hoffman EP; Angelini C
J Med Genet; 1997 Dec; 34(12):973-7. PubMed ID: 9429136
[TBL] [Abstract][Full Text] [Related]
3. Mutations in the delta-sarcoglycan gene are a rare cause of autosomal recessive limb-girdle muscular dystrophy (LGMD2).
Duggan DJ; Manchester D; Stears KP; Mathews DJ; Hart C; Hoffman EP
Neurogenetics; 1997 May; 1(1):49-58. PubMed ID: 10735275
[TBL] [Abstract][Full Text] [Related]
4. Disruption of heart sarcoglycan complex and severe cardiomyopathy caused by beta sarcoglycan mutations.
Barresi R; Di Blasi C; Negri T; Brugnoni R; Vitali A; Felisari G; Salandi A; Daniel S; Cornelio F; Morandi L; Mora M
J Med Genet; 2000 Feb; 37(2):102-7. PubMed ID: 10662809
[TBL] [Abstract][Full Text] [Related]
5. Autosomal recessive muscular dystrophy and mutations of the sarcoglycan complex.
Duggan DJ; Hoffman EP
Neuromuscul Disord; 1996 Dec; 6(6):475-82. PubMed ID: 9027858
[TBL] [Abstract][Full Text] [Related]
6. Mutations that disrupt the carboxyl-terminus of gamma-sarcoglycan cause muscular dystrophy.
McNally EM; Duggan D; Gorospe JR; Bönnemann CG; Fanin M; Pegoraro E; Lidov HG; Noguchi S; Ozawa E; Finkel RS; Cruse RP; Angelini C; Kunkel LM; Hoffman EP
Hum Mol Genet; 1996 Nov; 5(11):1841-7. PubMed ID: 8923014
[TBL] [Abstract][Full Text] [Related]
7. Mutations in the sarcoglycan genes in patients with myopathy.
Duggan DJ; Gorospe JR; Fanin M; Hoffman EP; Angelini C
N Engl J Med; 1997 Feb; 336(9):618-24. PubMed ID: 9032047
[TBL] [Abstract][Full Text] [Related]
8. Severe limb girdle muscular dystrophy in Spanish gypsies: further evidence for a founder mutation in the gamma-sarcoglycan gene.
Lasa A; Piccolo F; de Diego C; Jeanpierre M; Colomer J; Rodríguez MJ; Urtizberea JA; Baiget M; Kaplan J; Gallano P
Eur J Hum Genet; 1998; 6(4):396-9. PubMed ID: 9781048
[TBL] [Abstract][Full Text] [Related]
9. Mutations in the dystrophin-associated protein gamma-sarcoglycan in chromosome 13 muscular dystrophy.
Noguchi S; McNally EM; Ben Othmane K; Hagiwara Y; Mizuno Y; Yoshida M; Yamamoto H; Bönnemann CG; Gussoni E; Denton PH; Kyriakides T; Middleton L; Hentati F; Ben Hamida M; Nonaka I; Vance JM; Kunkel LM; Ozawa E
Science; 1995 Nov; 270(5237):819-22. PubMed ID: 7481775
[TBL] [Abstract][Full Text] [Related]
10. Sarcoglycan complex: a muscular supporter of dystroglycan-dystrophin interplay?
Matsumura K; Saito F; Yamada H; Hase A; Sunada Y; Shimizu T
Cell Mol Biol (Noisy-le-grand); 1999 Sep; 45(6):751-62. PubMed ID: 10541473
[TBL] [Abstract][Full Text] [Related]
11. Mild and severe muscular dystrophy caused by a single gamma-sarcoglycan mutation.
McNally EM; Passos-Bueno MR; Bönnemann CG; Vainzof M; de Sá Moreira E; Lidov HG; Othmane KB; Denton PH; Vance JM; Zatz M; Kunkel LM
Am J Hum Genet; 1996 Nov; 59(5):1040-7. PubMed ID: 8900232
[TBL] [Abstract][Full Text] [Related]
12. Genomic screening for beta-sarcoglycan gene mutations: missense mutations may cause severe limb-girdle muscular dystrophy type 2E (LGMD 2E).
Bönnemann CG; Passos-Bueno MR; McNally EM; Vainzof M; de Sá Moreira E; Marie SK; Pavanello RC; Noguchi S; Ozawa E; Zatz M; Kunkel LM
Hum Mol Genet; 1996 Dec; 5(12):1953-61. PubMed ID: 8968749
[TBL] [Abstract][Full Text] [Related]
13. Sarcoglycans in muscular dystrophy.
Hack AA; Groh ME; McNally EM
Microsc Res Tech; 2000 Feb 1-15; 48(3-4):167-80. PubMed ID: 10679964
[TBL] [Abstract][Full Text] [Related]
14. Beta-sarcoglycan: characterization and role in limb-girdle muscular dystrophy linked to 4q12.
Lim LE; Duclos F; Broux O; Bourg N; Sunada Y; Allamand V; Meyer J; Richard I; Moomaw C; Slaughter C
Nat Genet; 1995 Nov; 11(3):257-65. PubMed ID: 7581448
[TBL] [Abstract][Full Text] [Related]
15. Molecular and genetic characterization of sarcospan: insights into sarcoglycan-sarcospan interactions.
Crosbie RH; Lim LE; Moore SA; Hirano M; Hays AP; Maybaum SW; Collin H; Dovico SA; Stolle CA; Fardeau M; Tomé FM; Campbell KP
Hum Mol Genet; 2000 Aug; 9(13):2019-27. PubMed ID: 10942431
[TBL] [Abstract][Full Text] [Related]
16. Beta-sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex.
Bönnemann CG; Modi R; Noguchi S; Mizuno Y; Yoshida M; Gussoni E; McNally EM; Duggan DJ; Angelini C; Hoffman EP
Nat Genet; 1995 Nov; 11(3):266-73. PubMed ID: 7581449
[TBL] [Abstract][Full Text] [Related]
17. The clinical spectrum of sarcoglycanopathies.
Angelini C; Fanin M; Freda MP; Duggan DJ; Siciliano G; Hoffman EP
Neurology; 1999 Jan; 52(1):176-9. PubMed ID: 9921870
[TBL] [Abstract][Full Text] [Related]
18. Delivery of alpha- and beta-sarcoglycan by recombinant adeno-associated virus: efficient rescue of muscle, but differential toxicity.
Dressman D; Araishi K; Imamura M; Sasaoka T; Liu LA; Engvall E; Hoffman EP
Hum Gene Ther; 2002 Sep; 13(13):1631-46. PubMed ID: 12228018
[TBL] [Abstract][Full Text] [Related]
19. A novel gamma-sarcoglycan mutation causing childhood onset, slowly progressive limb girdle muscular dystrophy.
van der Kooi AJ; de Visser M; van Meegen M; Ginjaar HB; van Essen AJ; Jennekens FG; Jongen PJ; Leschot NJ; Bolhuis PA
Neuromuscul Disord; 1998 Jun; 8(5):305-8. PubMed ID: 9673983
[TBL] [Abstract][Full Text] [Related]
20. Sequential expression of genes involved in muscular dystrophies during human development.
Durand M; Suel L; Barbet JP; Beckmann JS; Fougerousse F
Morphologie; 2002 Jun; 86(273):9-12. PubMed ID: 12224393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
